PBIT is a reversible, cell-permeable inhibitor of JARID1 family demethylases (IC50s = 6, 3, 4.9, and 28 ?M for JARID1A, JARID1B, JARID1C, and JARID1D, respectively).
More Information Supplier PagePBIT is a reversible, cell-permeable inhibitor of JARID1 family demethylases (IC50s = 6, 3, 4.9, and 28 ?M for JARID1A, JARID1B, JARID1C, and JARID1D, respectively).
More Information Supplier PageVcMMAE is an antibody-drug conjugate (ADC) with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
More Information Supplier PageVcMMAE is an antibody-drug conjugate (ADC) with potent antitumor activity by using the anti-mitotic agent, monomethyl auristatin E (MMAE), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc).
More Information Supplier PageAR-C117977 is a potent MCT1 inhibitor, which can reduce vimmune responses both in vitro and in vivo, maintains long-term graft survival, and induces operational tolerance.
More Information Supplier PageAR-C117977 is a potent MCT1 inhibitor, which can reduce vimmune responses both in vitro and in vivo, maintains long-term graft survival, and induces operational tolerance.
More Information Supplier PageZ-LEHD-FMK is a synthetic peptide that irreversibly inhibits caspase-9 and related caspase activity.
More Information Supplier PageZ-LEHD-FMK is a synthetic peptide that irreversibly inhibits caspase-9 and related caspase activity.
More Information Supplier PageZ-LEHD-FMK is a synthetic peptide that irreversibly inhibits caspase-9 and related caspase activity.
More Information Supplier PageIB-MECA has been shown to act as a potent and selective Adenosine A3-R agonist with Ki values of 1.1, 54 and 56 nM for Adenosine A3-R, Adenosine A1-R and Adenosine A2A-R, respectively.
More Information Supplier Page
